PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

Mixed / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25034454 ↗2014Reported benefit

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

MixedIschaemia-reperfusionOther / unspecifiedMG53-knockout and wild-type mice; Sprague-Dawley and Wistar ratsMale and femaleIntravenous delivery or inhalation

Model: Ischaemia-reperfusion and overventilation-induced acute lung injury, emphysema and chronic lung injury models, with anoxia and reoxygenation in cultured lung epithelial cells

MG53-deficient mice were more susceptible to ischaemia-reperfusion and overventilation lung injury. Extracellular recombinant human MG53 protected cultured lung epithelial cells and, given intravenously or by inhalation, reduced injury in rodent models of acute lung injury and emphysema, with repea…

Extraction: extract · Supplied extraction confidence: 0.62. Machine-extracted fields require source verification.